Stone House Investment Management »

Recursion Pharmaceuticals shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.6k 1.0k 6.59
2024-03-31 $946 95 9.97

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Procter & Gamble Company (PG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Mbs Etf (MBB)
Ishares Msci Emrg Chn (EMXC)
Ishares Tr U.s. Tech Etf (IYW)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Stone House Investment Management

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
BlackRock
BlackRock
RA Capital Management
Mubadala Investment Co PJSC
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
State Street Corporation
MIC Capital Management UK
Nvidia Corp
Geode Capital Management
Exor Investments

View all funds holding Recursion Pharmaceuticals